CHRISTOPHER D. OZEROFF

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oruka Therapeutics, Inc.

Filing Date Source Excerpt
2013-02-01 Christopher D. Ozeroff is Secretary, Senior Vice President and General Counsel, and a director with beneficial ownership of 170,905 shares. No specific age, committees, or compensation details are provided.
2018-09-20 By Order of the Board of Directors: Christopher Ozeroff Secretary, Senior Vice President and General Counsel

Data sourced from SEC filings. Last updated: 2026-02-03